Axa S.A. Innoviva, Inc. Transaction History

Axa S.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$13.06 - $17.24 $1.2 Million - $1.59 Million	-92,100 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$9.33 - $12.48 $286,431 - $383,136	-30,700 Reduced 25.0%	92,100 $1.14 Million
Q3 2020 Nov 13, 2020	SELL	$10.33 - $14.49 $30,990 - $43,470	-3,000 Reduced 2.38%	122,800 $1.28 Million
Q2 2020 Aug 14, 2020	BUY	$11.49 - $15.26 $730,764 - $970,536	63,600 Added 102.25%	125,800 $1.76 Million
Q1 2020 May 15, 2020	BUY	$8.11 - $15.23 $504,441 - $947,306	62,200 New	62,200 $731,000

229

79.2M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.